Literature DB >> 27363402

Squamous cell carcinoma of unknown primary tumor metastatic to neck nodes: role of elective irradiation.

Primož Strojan1,2, Marko Kokalj3, Vesna Zadnik4, Aleksandar Aničin5, Gaber Plavc3, Vojislav Didanović6, Robert Šifrer5, Boštjan Lanišnik7.   

Abstract

In patients with squamous cell carcinoma (SCC) metastases to neck lymph nodes and unknown primary tumor, the role of elective irradiation of uninvolved neck and potential mucosal primary sites is yet to be determined. The aim of this study was to review the experience treating SCC of unknown primary metastatic to neck nodes with surgery and postoperative radiotherapy (PORT) in Slovenia between 1995 and 2010 and to determine the importance of the extent of irradiated volume. For this purpose, the nationwide Cancer Registry of Slovenia database was used for identifying patients. 126 patients were identified. Involved-field PORT and extended-field PORT was used in 50 and 76 patients, respectively. At 5 years, locoregional control was 86 %, disease-specific survival 77 %, and overall survival 57 %. In multivariate analysis, the extent of irradiated volume has not been predictive for any outcome under study. Grade ≥3 acute and late radiotherapy-induced toxicities were more frequent in the extended-field PORT group. In conclusion, although not superior, involved-field PORT seems to be a preferred treatment option in SCC of unknown primary metastatic to neck nodes due to significantly reduced toxicity and better prospects for successful salvage.

Entities:  

Keywords:  Cervical lymph node metastases; Postoperative radiotherapy; Squamous cell carcinoma; Surgery; Unknown primary tumor

Mesh:

Year:  2016        PMID: 27363402     DOI: 10.1007/s00405-016-4172-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

Review 1.  Cancer of unknown primary: does treatment modality make a difference?

Authors:  Ashley E Balaker; Elliot Abemayor; David Elashoff; Maie A St John
Journal:  Laryngoscope       Date:  2012-04-26       Impact factor: 3.325

2.  The future of induction chemotherapy for head and neck squamous cell carcinoma.

Authors:  Missak Haigentz; Ezra E W Cohen; Gregory T Wolf; Primož Strojan; Avraham Eisbruch; Alfio Ferlito
Journal:  Oral Oncol       Date:  2012-09-14       Impact factor: 5.337

Review 3.  Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches.

Authors:  Primož Strojan; Alfio Ferlito; Jesus E Medina; Julia A Woolgar; Alessandra Rinaldo; K Thomas Robbins; Johannes J Fagan; William M Mendenhall; Vinidh Paleri; Carl E Silver; Kerry D Olsen; June Corry; Carlos Suárez; Juan P Rodrigo; Johannes A Langendijk; Kenneth O Devaney; Luiz P Kowalski; Dana M Hartl; Missak Haigentz; Jochen A Werner; Phillip K Pellitteri; Remco de Bree; Gregory T Wolf; Robert P Takes; Eric M Genden; Michael L Hinni; Vanni Mondin; Ashok R Shaha; Leon Barnes
Journal:  Head Neck       Date:  2011-10-27       Impact factor: 3.147

4.  Survival in cancer of unknown primary site: population-based analysis by site and histology.

Authors:  K Hemminki; M Bevier; A Hemminki; J Sundquist
Journal:  Ann Oncol       Date:  2011-11-24       Impact factor: 32.976

5.  Transoral laser microsurgery for the unknown primary: role for lingual tonsillectomy.

Authors:  Thomas H Nagel; Michael L Hinni; Richard E Hayden; David G Lott
Journal:  Head Neck       Date:  2014-05-19       Impact factor: 3.147

6.  A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery.

Authors:  Vikas Mehta; Paul Johnson; Andrew Tassler; Seungwon Kim; Robert L Ferris; Melonie Nance; Jonas T Johnson; Umamaheswar Duvvuri
Journal:  Laryngoscope       Date:  2012-11-14       Impact factor: 3.325

7.  The occult head and neck primary: to treat or not to treat?

Authors:  K Sinnathamby; L J Peters; C Laidlaw; P G Hughes
Journal:  Clin Oncol (R Coll Radiol)       Date:  1997       Impact factor: 4.126

8.  Prognostic value of metastatic nodal volume and lymph node ratio in patients with cervical lymph node metastases from an unknown primary tumor.

Authors:  G C Park; J H Jung; J-L Roh; J H Lee; K-J Cho; S-H Choi; S Y Nam; S Y Kim
Journal:  Oncology       Date:  2014-04-08       Impact factor: 2.935

Review 9.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

10.  Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome.

Authors:  Lars Sivars; Anders Näsman; Nikolaos Tertipis; Andrea Vlastos; Torbjörn Ramqvist; Tina Dalianis; Eva Munck-Wikland; Sushma Nordemar
Journal:  Cancer Med       Date:  2014-02-10       Impact factor: 4.452

View more
  4 in total

1.  Treatment for retropharyngeal metastatic undifferentiated squamous cell carcinoma from an unknown primary site: results of a prospective study with irradiation to nasopharyngeal mucosa plus bilateral neck.

Authors:  Chengrun Du; Hongmei Ying; Youwang Zhang; Yafang Huang; Ruiping Zhai; Chaosu Hu
Journal:  Oncotarget       Date:  2017-06-27

2.  Carcinoma of unknown primary detected by whole-body diffusion-weighted imaging: A case report and review of the literature.

Authors:  Houyi Kang; Haitao He; Jie Ma; Jianliang Wen; Qiang Ma; Guangkuo Guo; Weiguo Zhang
Journal:  Radiol Case Rep       Date:  2020-05-12

3.  Long-term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study.

Authors:  Shengjin Dou; Rongrong Li; Lin Zhang; Zhuoying Wang; Li Xie; Chenping Zhang; Guopei Zhu
Journal:  Cancer Med       Date:  2020-01-17       Impact factor: 4.452

Review 4.  Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.

Authors:  Francisco J Civantos; Jan B Vermorken; Jatin P Shah; Alessandra Rinaldo; Carlos Suárez; Luiz P Kowalski; Juan P Rodrigo; Kerry Olsen; Primoz Strojan; Antti A Mäkitie; Robert P Takes; Remco de Bree; June Corry; Vinidh Paleri; Ashok R Shaha; Dana M Hartl; William Mendenhall; Cesare Piazza; Michael Hinni; K Thomas Robbins; Ng Wai Tong; Alvaro Sanabria; Andres Coca-Pelaz; Johannes A Langendijk; Juan Hernandez-Prera; Alfio Ferlito
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.